The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab combined with SOX in the first-line treatment of unresectable advanced or metastatic gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: A single-arm, prospective, and open-label clinical study.
 
Wenlou Liu
No Relationships to Disclose
 
Xiaobing Qin
No Relationships to Disclose
 
Yang Zhao
No Relationships to Disclose
 
Yan Ge
No Relationships to Disclose
 
Juanjuan Tang
No Relationships to Disclose
 
Hongmei Wang
No Relationships to Disclose
 
Zhengxiang Han
No Relationships to Disclose